Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Ambiguities need to be clarified
| The first 150 words of the full text of this article appear below. |
EDITOR
One of the priorities in the national service framework for
coronary heart disease summarised by Mayor1 was
"improved use of effective medicines after heart attack
especially
aspirin,
blockers, and statins
so that 80-90% of people
discharged from hospital after a heart attack will be prescribed these
drugs." This is the recommendation in the executive summary, which
taken at face value implies that all three drugs should be prescribed before a patient leaves hospital. In contrast, the recommendation in
the main document is that aspirin and
blocker treatment should be
started in hospital and statin treatment left for "continuing care."
Statin treatment was not started at the time of infarction in any of
the large secondary prevention studies. The shortest times from
infarction to inclusion were six months in the Scandinavian simvastatin
survival study (4S),2 and three months in the cholesterol and recurrent events (CARE) study3 and the long
Read all Rapid Responses